NDC00258-3634-01 — THEOPHYLLINE EXTENDED-RELEASE CA

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00258-3634-01: THEOPHYLLINE EXTENDED-RELEASE CA.

THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include special_features: ANHYDROUS, primary_container_type: BOTTLE, therapeutic_equivalent: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 1000S BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-173-1906, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00258-3634-01

NSN: 6505-01-173-1906
FSC: 6505 — Drugs and Biologicals
CAGE: 6X308 — INWOOD LABORATORIES INC (USA)

SPECIFICATIONS

special_features	ANHYDROUS
primary_container_type	BOTTLE
therapeutic_equivalent	SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
active_medicament_medicinal_strength	200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 1000S BT
capsule_primary_container_content_quantity	1000.000
NSN	6505-01-173-1906

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	SLO-BID GYROCAPS BY RORER PHARMACEUTICAL
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	ANHYDROUS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY	1000.000
PART NAME ASSIGNED BY CONTROLLING AGENCY	THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 1000S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

SUBSTITUTES & CROSS-REFERENCES 3

SLO-BID GYROCAPSReference document

Same NSN cross-reference

Reference document — Secondary reference

SLO-BIDReference document

Same NSN cross-reference

Reference document — Secondary reference

NDC00603-5951-21Reference document

Same NSN cross-reference

Reference document — Design control — primary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00258-3634-01?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00258-3634-01?

NDC00258-3634-01 is a THEOPHYLLINE EXTENDED-RELEASE CA.

What parts can replace NDC00258-3634-01?

There are 3 known substitutes for NDC00258-3634-01: SLO-BID GYROCAPS, SLO-BID, NDC00603-5951-21. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00258-3634-01?

NDC00258-3634-01 is cataloged in the U.S. Government catalog under NSN 6505-01-173-1906. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00258-3634-01 — THEOPHYLLINE EXTENDED-RELEASE CA

Request a Quote — NDC00258-3634-01